Concepedia

Robert R. Arrigale

RR

Statistics

Publications

4

Citations

676

H-Index

4

Active since

2003

Affiliations

Progenics Pharmaceuticals (United States)(Current)

Cleveland Clinic

Robert R. Arrigale is an author at Progenics Pharmaceuticals (United States) specializing in immunology, life sciences, and oncology.

Publications per year

2003–2012

4

Publications

4

L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus

Jason P. Gardner, Robert J. Durso, Robert R. Arrigale et al. · Proceedings of the National Academy of Sciences · 2003 · 291 citations · Full text

, , +17

The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy

Norbert Schülke, Olga A. Varlamova, Gerald P. Donovan et al. · Proceedings of the National Academy of Sciences · 2003 · 232 citations · Full text

, , +17

Protection Against Clostridium difficile Infection With Broadly Neutralizing Antitoxin Monoclonal Antibodies

Andre J. Marozsan, Dangshe Ma, Kirsten Nagashima et al. · The Journal of Infectious Diseases · 2012 · 83 citations · Full text

, , +17

A Novel Alphavirus Vaccine Encoding Prostate-Specific Membrane Antigen Elicits Potent Cellular and Humoral Immune Responses

Robert J. Durso, Sofija Andjelić, Jason P. Gardner et al. · Clinical Cancer Research · 2007 · 70 citations

, , +17

1–4 of 4